found that GLP-1 RAs are associated with an increased risk of gallbladder and biliary diseases (including cholelithiasis and cholecystitis), particularly at higher doses, longer treatment durations, and when used for weight loss [129]
Its definitely a common thing that were seeing in the office, said Marisa Garshick, MD, a board certified dermatologist and clinical assistant professor of dermatology at Weill Cornell Medicine
Because if weight loss comes at the expense of muscle mass, bone density, movement quality, and long-term physical resilience, the consequences may not fully show up until years later
Data on this topic is limitedand much of the research conducted on it so far has been funded by pharmaceutical companies, FWIW
His work centers on recovery routines, stress management, sleep-friendly wind-down habits, and sustainable wellness through heat and water-based therapies